Larimar Therapeutics Inc (LRMR)
7.38
-0.05
(-0.67%)
USD |
NASDAQ |
May 17, 16:00
7.38
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics Price to Book Value: 2.040 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.054 |
| May 15, 2024 | 2.175 |
| May 14, 2024 | 2.178 |
| May 13, 2024 | 2.023 |
| May 10, 2024 | 1.968 |
| May 09, 2024 | 2.172 |
| May 08, 2024 | 2.189 |
| May 07, 2024 | 2.247 |
| May 06, 2024 | 2.277 |
| May 03, 2024 | 2.146 |
| May 02, 2024 | 2.103 |
| May 01, 2024 | 2.031 |
| April 30, 2024 | 1.904 |
| April 29, 2024 | 1.827 |
| April 26, 2024 | 1.780 |
| April 25, 2024 | 1.750 |
| April 24, 2024 | 1.785 |
| April 23, 2024 | 1.785 |
| April 22, 2024 | 1.769 |
| April 19, 2024 | 1.805 |
| April 18, 2024 | 1.763 |
| April 17, 2024 | 1.948 |
| April 16, 2024 | 2.001 |
| April 15, 2024 | 2.018 |
| April 12, 2024 | 1.924 |
| Date | Value |
|---|---|
| April 11, 2024 | 1.995 |
| April 10, 2024 | 1.890 |
| April 09, 2024 | 1.946 |
| April 08, 2024 | 1.995 |
| April 05, 2024 | 2.056 |
| April 04, 2024 | 2.009 |
| April 03, 2024 | 2.134 |
| April 02, 2024 | 2.034 |
| April 01, 2024 | 2.062 |
| March 28, 2024 | 5.926 |
| March 27, 2024 | 5.672 |
| March 26, 2024 | 5.621 |
| March 25, 2024 | 5.918 |
| March 22, 2024 | 6.316 |
| March 21, 2024 | 6.683 |
| March 20, 2024 | 6.660 |
| March 19, 2024 | 6.706 |
| March 18, 2024 | 6.519 |
| March 15, 2024 | 6.792 |
| March 14, 2024 | 6.788 |
| March 13, 2024 | 7.261 |
| March 12, 2024 | 6.847 |
| March 11, 2024 | 6.721 |
| March 08, 2024 | 7.944 |
| March 07, 2024 | 8.505 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5413
Minimum
Aug 05 2022
9.953
Maximum
Feb 16 2024
2.208
Average
1.907
Median
Price to Book Value Benchmarks
| Cogent Biosciences Inc | 3.558 |
| ACADIA Pharmaceuticals Inc | 5.261 |
| PTC Therapeutics Inc | -- |
| Renovaro Inc | 3.197 |
| G1 Therapeutics Inc | 8.538 |
Price to Book Value Related Metrics
| Price | 7.38 |
| Earnings Yield | -13.01% |
| Market Cap | 470.86M |